Attention Deficit Hyperactivity Disorder (ADHD)
ADHD: Attention Deficit Hyperactivity Disorder
Resources
Basic InformationMore InformationTestsLatest NewsQuestions and AnswersBlog EntriesVideosLinksBook ReviewsSelf-Help Groups
Community

Talk about this issue in our mental health support community

Therapist Search
Find a Therapist:
 (USA/CAN only)

Use our Advanced Search to locate a therapist outside of North America.

Related Topics

Bipolar Disorder
Child & Adolescent Development Overview
Learning Disorders
View the Depression Primer - an illustrated book about Depression
Child Development and Parenting: Infants
Child Development and Parenting: Early Childhood

Attention-Deficit Drugs Linked to Better Test Scores

(HealthDay News)
by -- Eric Metcalf
Updated: Apr 29th 2009

new article illustration

WEDNESDAY, April 29 (HealthDay News) -- Children with attention-deficit/hyperactivity disorder (ADHD) who were medicated for the condition scored higher on math and reading tests than their unmedicated peers, according to research published in the May issue of Pediatrics.

Richard M. Scheffler, Ph.D., of the University of California in Berkeley, and colleagues analyzed data from 594 children with ADHD who were followed from kindergarten to fifth grade and were given math and reading achievement tests at five waves during this period. In the spring of the fifth-grade year, the medication rate was 67.7 percent.

The researchers found that children taking medication had a 2.9-point higher mean math score than unmedicated children. Those who were medicated during at least two waves had a 5.4-point higher mean reading score. These differences are comparable to gains attained during 0.19 and 0.29 school years, respectively, the authors note.

"Some 4.4 million children in the United States have been diagnosed with ADHD, a condition that is strongly associated with low academic achievement," the authors conclude. "With nearly 60 percent of diagnosed children taking prescription medications to treat the disorder, at a cost of $2.2 billion in 2003, the current findings have the potential for wide applicability, particularly because diagnostic prevalence and medication rates differ among demographic groups."

Abstract
Full Text (subscription or payment may be required)

Follow us on Twitter!

Find us on Facebook!





powered by centersite dot net